NO20063875L - Compounds used for the treatment of diseases - Google Patents

Compounds used for the treatment of diseases

Info

Publication number
NO20063875L
NO20063875L NO20063875A NO20063875A NO20063875L NO 20063875 L NO20063875 L NO 20063875L NO 20063875 A NO20063875 A NO 20063875A NO 20063875 A NO20063875 A NO 20063875A NO 20063875 L NO20063875 L NO 20063875L
Authority
NO
Norway
Prior art keywords
diseases
treatment
compounds used
compounds
disorders
Prior art date
Application number
NO20063875A
Other languages
Norwegian (no)
Inventor
Kim James
Mark Edward Bunnage
Alan Daniel Brown
Paul Alan Glossop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Priority claimed from PCT/IB2005/000640 external-priority patent/WO2005090287A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20063875L publication Critical patent/NO20063875L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det beskrives forbindelser av formel (1) og fremgangsmåter for fremstilling derav, mellomprodukter anvendt i fremstillingen derav, sammensetninger inneholdende disse og anvendelser av slike derivater. Forbindelsene i samsvar med foreliggende oppfinnelse er nyttige i en rekke sykdommer, forstyrrelser og tilstander, spesielt inflammatoriske, allergiske og respiratoriske sykdommer, forstyrrelser og tilstander.Compounds of formula (1) and processes for their preparation are disclosed, intermediates used in the preparation thereof, compositions containing them and uses of such derivatives. The compounds of the present invention are useful in a variety of diseases, disorders and conditions, especially inflammatory, allergic and respiratory diseases, disorders and conditions.

NO20063875A 2004-03-17 2006-08-30 Compounds used for the treatment of diseases NO20063875L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists

Publications (1)

Publication Number Publication Date
NO20063875L true NO20063875L (en) 2006-09-26

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063875A NO20063875L (en) 2004-03-17 2006-08-30 Compounds used for the treatment of diseases

Country Status (13)

Country Link
KR (1) KR20070026420A (en)
AP (1) AP2006003743A0 (en)
AR (1) AR048267A1 (en)
EC (1) ECSP066854A (en)
IL (1) IL177754A0 (en)
MA (1) MA28475B1 (en)
NL (1) NL1028559C2 (en)
NO (1) NO20063875L (en)
PA (1) PA8626401A1 (en)
PE (1) PE20060123A1 (en)
SV (1) SV2005002052A (en)
TW (1) TWI281396B (en)
UY (1) UY28810A1 (en)

Also Published As

Publication number Publication date
AR048267A1 (en) 2006-04-12
ECSP066854A (en) 2006-11-24
TW200534846A (en) 2005-11-01
PA8626401A1 (en) 2006-05-16
KR20070026420A (en) 2007-03-08
PE20060123A1 (en) 2006-03-08
AP2006003743A0 (en) 2006-10-31
TWI281396B (en) 2007-05-21
SV2005002052A (en) 2005-12-13
IL177754A0 (en) 2006-12-31
NL1028559A1 (en) 2005-09-20
NL1028559C2 (en) 2006-04-19
MA28475B1 (en) 2007-03-01
UY28810A1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
NO20062983L (en) Sulfonamide derivatives for the treatment of diseases
NO20063761L (en) Sulfonamide derivatives for the treatment of diseases
NO20084005L (en) amine derivatives
NO20064577L (en) Tetrahydronaphthindine derivatives useful as histamine H3 receptor ligands
EA200601462A1 (en) CONNECTIONS FOR THE TREATMENT OF DISEASES
NO20055854L (en) (2-Hydroxy-2- (4-hydroxy-3-hydroxymethylphenyl) ethylamino) propylphenyl derivatives as beta2 agonists
NO20050828L (en) indole-3-sulfur derivatives
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
WO2004080964A8 (en) Indole derivatives useful for the treatment of diseases
RS70104A (en) Nicotinamide derivatives useful as pde4 inhibitors
IL196543A (en) Pyridazinone derivatives and pharmaceutical compositions comprising them for use in the treatment of disorders
NO20056192L (en) Capase inhibitors and their use
NO20074592L (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
NO20063479L (en) Phosphonates, monophosphonamidates and bisphosphonamidates for the treatment of viral diseases
SE0301010D0 (en) Novel compounds
NO20045281L (en) Thiazolidinones and their use as polo-like kinase inhibitors
TW200607494A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
NO20090910L (en) Sulfonamide derivatives such as adrenergic agonists and muscarinic antagonists
NO20082496L (en) pyrazine derivatives
NO20074258L (en) Pyridine-2-carboxamide derivatives as MGLUR5 antagonists
SE0301009D0 (en) Novel compounds
NO20071577L (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory diseases
NO20051503L (en) Pyrazolopyridines and processes for the preparation and use of the same.
NO20073631L (en) Metasubstituted thiazolidinones, processes for the preparation and use thereof as drugs
EA200601510A1 (en) DERIVATIVES OF PHENYLETHANOLAMINE AS BETA-2-AGONISTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application